Best Long Run With Luke Timmerman Podcasts (2024)

1
Ep156: David Liu on New Tools and Techniques for Biology 1:52:57

5d ago1:52:57

1:52:57

David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.By Timmerman Report

1
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's 1:02:37

1M ago1:02:37

1:02:37

Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.By Timmerman Report

1
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer 1:03:14

2M ago1:03:14

1:03:14

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.By Timmerman Report

1
Ep153: Rick Young on Studying Gene Expression for Drug Discovery 1:01:43

3M ago1:01:43

1:01:43

Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.By Timmerman Report

1
Ep152: Jens Eckstein on Investing in Healthy Aging 1:05:05

3M ago1:05:05

1:05:05

Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.By Timmerman Report

1
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer 1:03:55

4M ago1:03:55

1:03:55

Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.By Timmerman Report

1
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance 1:03:48

4M ago1:03:48

1:03:48

Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.By Timmerman Report

1
Ep149: Nancy Stagliano on Precision Neuroscience 1:01:53

5M ago1:01:53

1:01:53

Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.By Timmerman Report

1
Ep148: Diana Brainard on the Fight Against Infectious Disease 1:03:27

5M ago1:03:27

1:03:27

Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.By Timmerman Report

1
Ep147: Reid Huber on Investing in the Future of Medicine 1:08:41

6M ago1:08:41

1:08:41

Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.By Timmerman Report

1
Ep146: Jeff Huber on Life in Tech and Biotech 1:47:05

6M ago1:47:05

1:47:05

Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.By Timmerman Report

1
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer 1:06:39

7M ago1:06:39

1:06:39

Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.By Timmerman Report

1
Ep144: Turning the Tables, Rob Perez Interviews Me 1:04:58

7M ago1:04:58

1:04:58

Turning the Tables, Rob Perez Interviews MeBy Timmerman Report

1
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders 1:10:25

8M ago1:10:25

1:10:25

Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech FoundersBy Timmerman Report

1
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be 55:54

8M ago55:54

55:54

Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.By Timmerman Report

1
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets 1:09:30

8M ago1:09:30

1:09:30

Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.By Timmerman Report

1
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas 1:02:40

9M ago1:02:40

1:02:40

Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.By Timmerman Report

1
Ep139: Kevin Conroy on Early Detection of Cancer 1:08:28

9M ago1:08:28

1:08:28

Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.By Timmerman Report

1
Ep138: Jodie Morrison on Becoming a Biotech CEO 1:00:17

10M ago1:00:17

1:00:17

Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.By Timmerman Report

1
Ep137: Aaron Ring on Immunotherapy for Cancer & More 56:37

10M ago56:37

56:37

Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.By Timmerman Report

1
Ep136: Deborah Palestrant on Building Biotech Startups 52:52

11M ago52:52

52:52

Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.By Timmerman Report

1
Ep135: John Maraganore on Developing a New Class of Medicines 1:03:51

12M ago1:03:51

1:03:51

John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.By Timmerman Report

1
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies 1:16:22

12M ago1:16:22

1:16:22

Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.By Timmerman Report

1
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies 1:10:33

1y ago1:10:33

1:10:33

Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.By Timmerman Report

1
Ep132: Eric Dobmeier on Treating Kidney Disease 1:05:44

1y ago1:05:44

1:05:44

Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.By Timmerman Report

1
Ep131: Ryan Watts on Neuroscience Drug R&D 1:05:32

1y ago1:05:32

1:05:32

Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.By Timmerman Report

1
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave 1:09:29

1y ago1:09:29

1:09:29

David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.By Timmerman Report

1
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies 1:11:43

1y ago1:11:43

1:11:43

Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.By Timmerman Report

1
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last 1:00:34

1y ago1:00:34

1:00:34

Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.By Timmerman Report

1
Ep127: Jeb Keiper on Computational Drug Discovery 1:09:41

1y ago1:09:41

1:09:41

Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.By Timmerman Report

1
Ep126: DA Wallach on Becoming a Biotech VC 1:11:38

1+ y ago1:11:38

1:11:38

DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.By Timmerman Report

1
Ep125: Barry Greene on a New Drug for Depression 1:04:52

1+ y ago1:04:52

1:04:52

Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.By Timmerman Report

1
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines 1:09:53

1+ y ago1:09:53

1:09:53

Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.By Timmerman Report

1
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery 1:15:26

1+ y ago1:15:26

1:15:26

Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.By Timmerman Report

1
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders 1:00:04

1+ y ago1:00:04

1:00:04

Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.By Timmerman Report

1
Ep121: Samantha Truex on Going Upstream Against Severe Asthma 1:03:49

1+ y ago1:03:49

1:03:49

Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.By Timmerman Report

1
Ep120: Tim Lu on Gene Circuits for Cell Therapy 1:04:14

1+ y ago1:04:14

1:04:14

Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.By Timmerman Report

1
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease 1:02:42

1+ y ago1:02:42

1:02:42

Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.By Timmerman Report

1
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes 1:08:08

1+ y ago1:08:08

1:08:08

Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.By Timmerman Report

1
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World 1:01:24

2y ago1:01:24

1:01:24

Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.By Timmerman Report

1
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience 58:35

2y ago58:35

58:35

Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.By Timmerman Report

1
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing 59:21

2y ago59:21

59:21

Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.By Timmerman Report

1
Ep114: Chris Gibson on Industrializing Drug Discovery 1:06:33

2y ago1:06:33

1:06:33

Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.By Timmerman Report

1
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs 40:07

2y ago40:07

40:07

Lewis Cantley and Siddhartha Mukherjee, co-founders of Faeth Therapeutics, on fighting cancer with food and drug combinations.By Timmerman Report

1
Ep112: Bernat Olle on Microbiome Therapeutics 1:06:26

2y ago1:06:26

1:06:26

Bernat Olle, CEO of Vedanta Biosciences, on developing microbiome therapeutics.By Timmerman Report

1
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery 1:02:42

2y ago1:02:42

1:02:42

Ray Stevens, CEO of ShouTi, on structural biology driven drug discovery.By Timmerman Report

1
Ep110: Michele Andrasik on Making Clinical Trials More Diverse 1:07:25

2y ago1:07:25

1:07:25

Michele Andrasik, a clinical health psychologist at the Fred Hutchinson Cancer Research Center, on improving community outreach and diversity in clinical trials.By Timmerman Report